Showing results (71-80 of 330) with videos related to

Sort By:
Pageof 33
Diabetes & Vascular Disease Research|March 23, 2021
Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trialAnne Wang, Hertzel C Gerstein, Shun Fu Lee, et al.
European Journal of Endocrinology|June 5, 2015
Coronary artery disease risk among obese metabolically healthy young menGilad Twig, Hertzel C Gerstein, Dana Ben-Ami Shor, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2021
The Relationship Between Glucose Control and Cognitive Function in People With Diabetes After a Lacunar StrokeTali Cukierman-Yaffe, Leslie A McClure, Thomas Risoli, et al.
Canadian Journal of Diabetes|August 6, 2025
Can a Combined Epigenetic-Biomarker Score Supplant Chronologic Age as an Independent Determinant of Incident Death in Adults with DysglycemiaHertzel C Gerstein, Guillaume Pare, Keyun Zhou, et al.
Plos One|October 15, 2008
Fetal and neonatal nicotine exposure in Wistar rats causes progressive pancreatic mitochondrial damage and beta cell dysfunctionJennifer E Bruin, Maria A Petre, Sandeep Raha, et al.
Diabetes Care|January 19, 2022
HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND TrialAnita Y M Kwan, Hertzel C Gerstein, Jan Basile, et al.
Diabetes & Vascular Disease Research|April 14, 2017
The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trialAslak Rautio, Kurt Boman, Hertzel C Gerstein, et al.
Diabetes/Metabolism Research and Reviews|August 1, 2018
Minimally important difference and predictors of change in quality of life in type 2 diabetes: A community-based survey in ChinaXuejing Jin, Gordon G Liu, Hertzel C Gerstein, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|February 27, 2013
Postnatal metabolic and reproductive consequences of fetal and neonatal exposure to the smoking cessation drug bupropionNicole De Long, Jillian R Hyslop, Catherine J Nicholson, et al.
Diabetes Care|October 31, 2013
Does a patient-managed insulin intensification strategy with insulin glargine and insulin glulisine provide similar glycemic control as a physician-managed strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study: a randomized noninferiority trialStewart B Harris, Jean-François Yale, Lori Berard, et al.
Pageof 33